Back to Search
HOWARD FINE, MD MHSC
MD MHSC
Retina Specialist (Ophthalmology) Physician
NPI: 1295810059IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology Physician
Ophthalmology
Code: 207W00000X
25MA08413300(NJ)
Retina Specialist (Ophthalmology) PhysicianPrimary
Ophthalmology — Retina Specialist
Code: 207WX0107X
25MA08413300(NJ)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 2001
Research & Publications (20)
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
PMID 19562255·J Neurooncol·2010
3-trial
Acute posterior multifocal placoid pigment epitheliopathy following varicella vaccination.
PMID 18728052·Br J Ophthalmol·2010
5-case
SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.
PMID 19427293·Cell Stem Cell·2009
7-preclinical
Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes.
PMID 19244127·Cancer Res·2009
8-other
Occupational exposure to magnetic fields and the risk of brain tumors.
PMID 19234232·Neuro Oncol·2009
8-other
Corneal verticillata after dual anti-epidermal growth factor receptor and anti-vascular endothelial growth factor receptor 2 therapy (vandetanib) for anaplastic astrocytoma.
PMID 19512898·Cornea·2009
5-case
Acute zonal occult outer retinopathy in patients with multiple evanescent white dot syndrome.
PMID 19139340·Arch Ophthalmol·2009
5-case
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
PMID 19293394·Neuro Oncol·2009
3-trial
Common variation in genes related to innate immunity and risk of adult glioma.
PMID 19423540·Cancer Epidemiol Biomarkers Prev·2009
8-other
Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes.
PMID 19190341·Cancer Res·2009
8-other
Subfoveal pigment changes in patients with longstanding epiretinal membranes.
PMID 19232558·Am J Ophthalmol·2009
8-other
Rembrandt: helping personalized medicine become a reality through integrative translational research.
PMID 19208739·Mol Cancer Res·2009
8-other
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.
PMID 19636006·J Clin Oncol·2009
3-trial
Intravitreal injection of tissue plasminogen activator as treatment for an occluded pars plana glaucoma tube.
PMID 19668550·Clin Ophthalmol·2009
5-case
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.
PMID 19114704·J Clin Oncol·2009
3-trial
A phase I trial of enzastaurin in patients with recurrent gliomas.
PMID 19417015·Clin Cancer Res·2009
3-trial
Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis.
PMID 18784620·Retina·2009
5-case
Cellular origin of fundus autofluorescence in patients and mice with a defective NR2E3 gene.
PMID 19429590·Br J Ophthalmol·2009
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10 PLUM ST, SUITE 600
NEW BRUNSWICK, NJ 08901 - Phone
- (732) 220-1600
Quick Facts
- NPI
- 1295810059
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile